iuvantium mundum – helping the world
We are a deeptech synthetic immunobiology company developing new modalities for the next generation of immunotherapies
CURING AS MANY PEOPLE AS POSSIBLE FROM DISEASE
MAKING THE WORLD STRONGER, TOGETHER
We do this by applying AI and materials science to engineer a new modality of inorganic immune modulators with predictable immune responses to enable the next generation of therapeutics for immunological diseases.
We believe in the power of helping others and in humanity’s desire to do good,
that change can be initiated by individuals and must be carried forward by many,
and that, together, we can make the world stronger.
At iuvantium, our mission is to harness the power of cross disciplinary collaboration, cutting-edge technology, and ethical principles to revolutionize the field of immunotherapy. We strive to create a world where everyone, regardless of their background or circumstances, has access to the best healthcare and are committed to the principles of equality, diversity, and inclusivity.
By merging immunobiology, materials science, AI, and engineering principles we develop a scalable and cost-effective immune modulation platform. Our platform empowers immunotherapy developers to enhance the effectiveness of a vaccine/drug’s performance in real life settings and improve accessibility of their formulations, leading to breakthrough treatments for cancer and infectious diseases.
We envision a future where the power of human compassion and collaboration transcends boundaries, making transformative healthcare solutions available to all. We aspire to be at the forefront of innovation in the field of immune therapies, revolutionizing the way diseases are treated and prevented.
By decoding the intricacies of the immune system and harnessing the potential of inorganic materials, we pioneer novel approaches that shape the development of next-generation vaccines, cellular therapies and drugs. Our vision is to serve as the catalyst for positive change, partnering with pharmaceutical companies to realize a world free from the shackles of cancer and infectious diseases. Through our work, we envision a future where preventable suffering is eradicated, lives are saved, and individuals are empowered to reach their fullest potential. Together, we will build a world where healthcare knows no boundaries and the human spirit flourishes.
Every challenge is an opportunity
We build trust with transparency and through honest relationships
We do our best work as a team
We hold each other accountable
“Nana korobi, ya oki” – “Fall down seven times, stand up 8″
We believe in the infinite game – we always take the long view
Our Technology Aspiration
Deliver a highly flexible immunomodulator platform, which unlocks the full potential for each therapy and enables optimization and complete customization of therapeutic and vaccine formulations
By harvesting the flexibility of inorganic chemistry, we maximize a nanomaterial’s potential to deliver the most advanced immunomodulator functionality in therapeutic drug formulations today. That’s because the compositional freedom and control of physicochemical material properties allows us to tailor the immunomodulator system to the targeted disease and/or antigen platform.
Expanding Immunotherapy Utility
Our platform enables administration in liquid or dry state. It is agnostic to type of therapy – prophylactic or therapeutic.
Our Business Model
Through industry partnership, we can address some of the most pressing challenges that hinder the fight against cancers and infectious diseases today.
We actively seek new partners to increase the chances of a successful treatment or cure, so that as many people as possible realize a new opportunity to seize their potential.
We welcome partnerships via a tailored revenue-share agreement. If you are a immunetherapy developer, let’s talk.
Together, we can make the world stronger.
Let us inspire you to rethink your drug formulation
We greatly appreciate those that joined our adventure and believe in our WHY
We are proud recipient of a Innovate UK research grant and excited by UKRI’s validation and believe in our mission and vision.